BofA/Merrill Lynch Downgrades Emerson (EMR) to Neutral
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $138.88 +0.78%
Rating Summary:
25 Buy, 21 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
25 Buy, 21 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Emerson (NYSE: EMR) from Buy to Neutral.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $44.01 yesterday.
For more ratings news on Emerson click here and for the rating history of Emerson click here.
Shares of Emerson closed at $44.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Houlihan Lokey (HLI) at Buy
- Bank of New York Mellon (BK) PT Raised to $87 at BofA Securities
- Apnimed files for initial public offering on Nasdaq
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
